Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent radiotherapy with finotonlimab and cisplatin for oropharyngeal cancer
ChiCTR2600127719Phase 4Recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Jul 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of finotonlimab in oropharyngeal cancer, sponsored by The First Hospital of Jilin University. Primary endpoint: Objective response rate (ORR). Started Jul 2026; status: recruiting.
02
Drugs
finotonlimab
03
Conditions
oropharyngeal cancer
Beyond the preview
Go deeper on ChiCTR2600127719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127719.